Brief: Advicenne announces commercialization agreement with FrostPharma AB for Sibnayal™ in the Nordic region
Jan 4 (Reuters) - Advicenne SA ADVIC.PA :
* ADVICENNE ANNOUNCES COMMERCIALIZATION AGREEMENT WITH
FROSTPHARMA
AB FOR SIBNAYAL™ IN THE NORDIC REGION
* ADVICENNE SA - ADVICENNE WILL RECEIVE A TRANSFER PRICE AND
ROYALTIES FOR AN AMOUNT MARKEDLY HIGHER THAN 50% OF FUTURE SALES
OF SIBNAYAL
Source text for Eikon: ID:nGNX7fGzbr
Further company coverage: ADVIC.PA
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Advicenne SA
See all newsBrief: Advicenne Secures Cash Runway To Q2 2027 Through Bond Financing Of Amount Of Up To €3.8 Mln
Corrected: BRIEF-Advicenne FY Net Income EUR -9.532 Million (March 26)
France's Advicenne 2025 sales rise, net loss widens
Brief: Advicenne FY Net Income EUR -9.532 Million
Brief: Advicenne SA -Cash Position Of EUR 2.0 Million With Unchanged Financial Visibility In Q1 2025